Satellos Bioscience Inc (ICOTF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ICOTF | CMMB | ALZN | ||
| Company | Satellos Bioscience Inc | Chemomab Therapeutics Ltd ADR | Alzamend Neuro Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.9380 | 1.5800 | 1.9900 | ||
| High | 0.9387 | 1.5800 | 2.0200 | ||
| Low | 0.9380 | 1.5000 | 1.9500 | ||
| Latest | 0.9387 | 1.5300 | 1.9900 | ||
| Change | -0.0123 | -0.0400 | +0.0200 | ||
| % Change | -1.29% | -2.55% | +1.02% | ||
| Volume | 5,200 | 9,838 | 17,038 | ||
| 20-Day Average Volume | 5,030 | 94,054 | 80,139 | ||
| Previous Close | 0.9510 | 1.5700 | 1.9700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.0299 | 1.5820 | 1.9635 | ||
| 20-Day Raw Stochastic | 10.32% | 28.10% | 61.76% | ||
| 20-Day Relative Strength | 41.32 | 41.72 | 48.70 | ||
| Weighted Alpha | N/A | -76.67 | -64.05 | ||
| Today's Opinion | N/A | 100% Sell | 88% Sell | ||
| Previous Opinion | N/A | 100% Sell | 100% Sell | ||
| Last Month's Opinion | N/A | 100% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.42% since 11/30/21 | +0.66% since 02/13/26 | +22.70% since 02/13/26 | ||
| Low | 0.9000 on 12/06/21 | 1.4000 on 02/18/26 | 1.5800 on 02/17/26 | ||
| High | 1.0700 on 12/08/21 | 1.6400 on 02/19/26 | 2.0600 on 02/19/26 | ||
| 1-Month | |||||
| %Chg | -12.60% since 11/09/21 | -9.52% since 01/23/26 | -9.09% since 01/23/26 | ||
| Low | 0.9000 on 12/06/21 | 1.4000 on 02/18/26 | 1.5800 on 02/17/26 | ||
| High | 1.1422 on 11/26/21 | 1.8270 on 01/26/26 | 2.2600 on 01/26/26 | ||
| 3-Month | |||||
| %Chg | -16.19% since 09/09/21 | -39.92% since 11/21/25 | +2.04% since 11/21/25 | ||
| Low | 0.8000 on 10/11/21 | 1.4000 on 02/18/26 | 1.5800 on 02/17/26 | ||
| High | 1.3300 on 10/07/21 | 2.7700 on 12/08/25 | 2.5350 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | N/A since 08/18/21 | -57.30% since 08/22/25 | -19.68% since 08/22/25 | ||
| Low | 0.8000 on 10/11/21 | 1.4000 on 02/18/26 | 1.5800 on 02/17/26 | ||
| High | 1.8182 on 08/18/21 | 3.8550 on 08/26/25 | 2.6800 on 10/31/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,499 | 9,663 | 7,489 | ||
| Shares Outstanding, K | 9,054 | 6,155 | 3,802 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -1,110,000 | -13,950,000 | -4,510,000 | ||
| Last Quarter Sales | 40,000 | 0 | 0 | ||
| Last Quarter Net Income | -700,000 | -1,740,000 | -1,000,000 | ||
| 60-Month Beta | 2.03 | 0.56 | -0.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.36 on 08/14/25 | -0.30 on 12/09/25 | ||
| Latest Earnings Date | 05/05/22 | 03/02/26 | 03/09/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||